Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,7 USD | -3,41 % | 0,00 % | +8,12 % |
28/03 | Reneo Pharmaceuticals, Inc. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023 | CI |
2023 | RENEO PHARMACEUTICALS, INC. : Ladenburg Thalmann es ahora neutral | ZM |
Resumen de negocios
Número de empleados: 8
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Niall O'Donnell
FOU | Founder | 51 | - |
Gregory Flesher
CEO | Chief Executive Officer | 54 | 09/12/20 |
Michael Grey
FOU | Founder | 71 | 22/09/14 |
Jennifer P. Lam
ADM | Chief Administrative Officer | - | 01/08/21 |
Michael Cruse
COO | Chief Operating Officer | 52 | 01/12/20 |
Chief Tech/Sci/R&D Officer | 64 | 01/01/18 | |
Ashley Hall
PRN | Corporate Officer/Principal | 52 | 11/10/21 |
Corporate Officer/Principal | - | 01/01/18 | |
Wendy Johnson
PRN | Corporate Officer/Principal | 72 | 01/01/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Michael Grey
FOU | Founder | 71 | 22/09/14 |
Director/Board Member | 64 | 01/12/17 | |
Paul Hoelscher
BRD | Director/Board Member | 59 | 20/01/22 |
Gregory Flesher
CEO | Chief Executive Officer | 54 | 09/12/20 |
Stacey Seltzer
BRD | Director/Board Member | 47 | 01/12/20 |
Niall O'Donnell
FOU | Founder | 51 | - |
Bali Muralidhar
BRD | Director/Board Member | 44 | 01/04/21 |
Roshawn Blunt
BRD | Director/Board Member | 49 | 01/01/22 |
Eric Dube
BRD | Director/Board Member | 51 | 15/03/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 33 420 808 | 32 416 707 ( 97,00 %) | 0 | 97,00 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+8,12 % | 58,82 M | |
-2,37 % | 41,35 mil M | |
+42,15 % | 40,38 mil M | |
+1,21 % | 39,05 mil M | |
-14,19 % | 26,67 mil M | |
+1,49 % | 24,07 mil M | |
-24,99 % | 18,36 mil M | |
-4,37 % | 11,68 mil M | |
+20,27 % | 11,6 mil M | |
+7,62 % | 11,15 mil M |
- Bolsa de valores
- Acciones
- Acción RPHM
- Empresa Reneo Pharmaceuticals, Inc.